Recruiting now
-
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 · randomised · 134 people · 2 sites in United States · Recruiting now
-
Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
Phase 2 · randomised · 236 people · 1 site in China · Recruiting now
-
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer
Phase 2 · 197 people · 1 site in Italy · Recruiting now
-
A Study of DM002 in Patients With Advanced Solid Tumors
Phase 2 · 280 people · 7 sites in 2 countries · Recruiting now
-
Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery
Phase 2 · randomised · 100 people · 1 site in Slovenia · Recruiting now
-
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Phase 2 · 47 people · 27 sites in 9 countries · Recruiting now
-
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer
Phase 2 · 60 people · 14 sites in United States · Recruiting now
-
A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
Phase 1 · randomised · 180 people · 26 sites in Russia · Recruiting now